MWNA
RARE icon

Marshall Wace North America’s Ultragenyx Pharmaceutical RARE Stock Holding History

Marshall Wace North America’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$18.6M Buy
206,420
+75,859
+58% +$6.86M 0.08% 244
2021
Q2 		$12.4M Buy
+130,561
New +$13.6M 0.05% 339
2021
Q1 		– Sell
-5,160
Closed -$715K – 1729
2020
Q4 		$715K Buy
+5,160
New +$612K ﹤0.01% 1016
2018
Q4 		– Sell
-3,212
Closed -$245K – 1603
2018
Q3 		$245K Buy
+3,212
New +$261K ﹤0.01% 819
2018
Q1 		– Sell
-12,652
Closed -$587K – 1655
2017
Q4 		$587K Buy
+12,652
New +$620K ﹤0.01% 1112

Other funds holding RARE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return